Literature DB >> 31741886

Risk factors for high-volume lymph node metastases in cN0 papillary thyroid microcarcinoma.

Chunhao Liu1, Yuewu Liu1, Lei Zhang2, Yunwei Dong3, Shenbao Hu4, Yu Xia5, Bo Zhang5, Yue Cao1, Ziwen Liu1, Ge Chen1, Zhonghua Shang6, Jinbao Yang7, Qinghe Sun8, Xiaoyi Li1.   

Abstract

BACKGROUND: Lymph node metastasis (LNM) often occurs in clinical lymph node negative (cN0) papillary thyroid microcarcinoma (PTMC). The risk factors for LNM, especially for high-volume LNM, were investigated in this study.
METHODS: The medical records of 1,974 consecutive PTMC patients admitted to the Peking Union Medical College Hospital (PUMCH) from 2013 to 2015 were reviewed. Their clinicopathological features were collected. Univariate and multivariate analyses were performed to identify the risk factors for LNM/high-volume LNM.
RESULTS: Of all the patients, cervical lymph node metastases were detected in 690 patients (34.95%), and high-volume LNM was detected in 75 patients (3.80%). The results of univariate analysis revealed that sex, age, chronic thyroiditis, multifocality, and tumor diameter were significantly correlated with LNM (P<0.05) and that sex, age, multifocality, and tumor diameter were significantly correlated with high-volume LNM (P<0.05). Multivariate logistic regression analysis demonstrated that male sex [odds ratio (OR) =1.657, P<0.001], multifocality (OR =1.601, P<0.001), and tumor diameter >0.5 cm (OR =1.770, P<0.001) were independent risk factors for LNM; age of 40-59 years old (OR =0.427, P<0.001), age ≥60 years old (OR =0.291, P<0.001), and chronic thyroiditis (OR =0.562, P<0.001) were independent protective factors for LNM. For high-volume LNM, male sex (OR =2.250, P=0.002), tumor diameter >0.5 cm (OR =3.664, P=0.013) and multifocality (OR =2.034, P=0.004) were independent risk factors, whereas age ≥40 years old (OR =0.240, P<0.001) was an independent protective factor.
CONCLUSIONS: Lymph node metastases are common in cN0 PTMC, whereas high-volume LNM is rare. Active surveillance may be reasonable for patients with tumor diameter ≤0.5 cm, age ≥40 years old, female sex and isolated lesions. 2019 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Clinical lymph node negative; high-volume lymph node metastases; papillary thyroid microcarcinoma (PTMC); risk factors

Year:  2019        PMID: 31741886      PMCID: PMC6842761          DOI: 10.21037/gs.2019.10.04

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  34 in total

1.  Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: A retrospective study of 1,391 prospective documented patients.

Authors:  Elisabeth Gschwandtner; Tobias Klatte; Natalia Swietek; Claudia Bures; Friedrich Kober; Johannes Ott; Andrea Schultheis; Nikolaus Neuhold; Michael Hermann
Journal:  Surgery       Date:  2015-07-17       Impact factor: 3.982

2.  Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection.

Authors:  I J Nixon; L Y Wang; I Ganly; S G Patel; L G Morris; J C Migliacci; R M Tuttle; J P Shah; A R Shaha
Journal:  Br J Surg       Date:  2015-10-29       Impact factor: 6.939

3.  Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.

Authors:  Young Chan Lee; Se Young Na; Gi Cheol Park; Ju Hyun Han; Seung Woo Kim; Young Gyu Eun
Journal:  Surgery       Date:  2016-08-26       Impact factor: 3.982

Review 4.  Management of patients with low-risk papillary thyroid carcinoma.

Authors:  Ian D Hay
Journal:  Endocr Pract       Date:  2007-09       Impact factor: 3.443

Review 5.  Management of low-risk differentiated thyroid cancer.

Authors:  Ernest L Mazzaferri
Journal:  Endocr Pract       Date:  2007-09       Impact factor: 3.443

6.  Current thyroid cancer trends in the United States.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-04       Impact factor: 6.223

7.  Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma.

Authors:  Lei Zhang; Hongfeng Liu; Yong Xie; Yu Xia; Bo Zhang; Guangliang Shan; Xiaoyi Li
Journal:  Eur J Surg Oncol       Date:  2015-11-14       Impact factor: 4.424

8.  Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma.

Authors:  Dana M Hartl; Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Martin Schlumberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

Review 9.  The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.

Authors:  Gregory W Randolph; Quan-Yang Duh; Keith S Heller; Virginia A LiVolsi; Susan J Mandel; David L Steward; Ralph P Tufano; R Michael Tuttle
Journal:  Thyroid       Date:  2012-10-19       Impact factor: 6.568

Review 10.  Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Wei Sun; Xiabin Lan; Hao Zhang; Wenwu Dong; Zhihong Wang; Liang He; Ting Zhang; Siming Liu
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

View more
  10 in total

1.  Predicting factors of central lymph node metastases in patients with unilateral multifocal papillary thyroid microcarcinoma.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng; Xiaodong He
Journal:  Gland Surg       Date:  2020-06

2.  Artificial Neural Network-Based Ultrasound Radiomics Can Predict Large-Volume Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients.

Authors:  Wan Zhu; Xingzhi Huang; Qi Qi; Zhenghua Wu; Xiang Min; Aiyun Zhou; Pan Xu
Journal:  J Oncol       Date:  2022-06-17       Impact factor: 4.501

3.  LMCD1 antisense RNA 1 (LMCD1-AS1) potentiates thyroid cancer cell growth and stemness via a positive feedback loop of LMCD1-AS1/miR-1287-5p/GLI2.

Authors:  Jie Shao; Yonggang Xu; Haixia Li; Lu Chen; Wenjuan Wang; Danfeng Shen; Jinhong Chen
Journal:  Ann Transl Med       Date:  2020-11

4.  A Nomogram Based on Clinicopathological and Ultrasound Imaging Characteristics for Predicting Cervical Lymph Node Metastasis in cN0 Unilateral Papillary Thyroid Microcarcinoma.

Authors:  Lina Zhang; Yuwei Ling; Ye Zhao; Kaifu Li; Jing Zhao; Hua Kang
Journal:  Front Surg       Date:  2021-12-03

5.  Large-Volume Lateral Lymph Node Metastasis Predicts Worse Prognosis in Papillary Thyroid Carcinoma Patients With N1b.

Authors:  Luying Gao; Xiaoyi Li; Yu Xia; Ruifeng Liu; Chunhao Liu; Xinlong Shi; Yanjiao Wu; Liyuan Ma; Yuxin Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-02       Impact factor: 5.555

6.  Active surveillance of highly suspicious thyroid nodules cohort in China shows a worse psychological status in younger patients.

Authors:  Chunhao Liu; Hao Zhao; Yu Xia; Yue Cao; Liyang Zhang; Ya Zhao; Luying Gao; Ruifeng Liu; Yuewu Liu; Hongfeng Liu; Zhilan Meng; Shuzhou Liu; Xiaoyi Li
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

7.  The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway.

Authors:  Zhen-Xing Yu; Cheng Xiang; Sheng-Gui Xu; Yang-Ping Zhang
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

8.  Predictive Factor of Large-Volume Central Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients Underwent Total Thyroidectomy.

Authors:  Jianhao Huang; Muye Song; Hongyan Shi; Ziyang Huang; Shujie Wang; Ying Yin; Yijie Huang; Jialin Du; Sanming Wang; Yongchen Liu; Zeyu Wu
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

9.  Prediction mode of more than 5 central lymph nodes metastases in clinically node-negative ipsilateral papillary thyroid carcinoma with tumor size 1 to 4 cm.

Authors:  Lei Jin; Hai-Li Sun; Liang Zhou; Lei Xie; Yi-Yu Zhuang; Jian-Biao Wang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

10.  Predicting non-small-volume central lymph node metastases (>5 or ≥2 mm) preoperatively in cN0 papillary thyroid microcarcinoma without extrathyroidal extension.

Authors:  Jin-Duo Shou; Fei-Bo Li; Liu-Hong Shi; Liang Zhou; Lei Xie; Jian-Biao Wang
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.